Evidence map›Paper›PMID 33315872›Full record

ArticlePloS one2020

Impact of duration and magnitude of raised intracranial pressure on outcome after severe traumatic brain injury: A CENTER-TBI high-resolution group study.

Cecilia Ai Åkerlund, Joseph Donnelly, Frederick A Zeiler, Raimund Helbok, Anders Holst, Manuel Cabeleira, Fabian Güiza, Geert Meyfroidt, Marek Czosnyka, Peter Smielewski and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06429657 (Ketamine for Sedation in Severe Traumatic Brain Injury), which is not on this map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06429657 phase4suspendednot on this mapstarted 2024, after this paper: background citation

Ketamine for Sedation in Severe Traumatic Brain Injury

TypeinterventionalSponsorHenry M. Jackson Foundation for the Advancement of Military MedicineRan2024 to 2027Enrolled50ConditionsSevere Traumatic Brain Injury, Intracranial Hypertension, Intracranial Hemorrhage, HypertensiveArmsKetamine with propofol, Standard of Care propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 7 countries.

Cecilia Ai ÅkerlundDepartment of Physiology and Pharmacology, Section of Perioperative Medicine and Intensive Care, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4918-1482
Joseph DonnellyClinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Frederick A ZeilerSection of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Raimund HelbokDepartment of Neurology, Neurological Intensive Care Unit, Medical University of Innsbruck, Innsbruck, Austria.
Anders HolstSchool of Computer Science and Communication, KTH Royal Institute of Technology, Stockholm, Sweden.
Manuel CabeleiraClinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Fabian GüizaDepartment and Laboratory of Intensive Care Medicine, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
Geert MeyfroidtDepartment and Laboratory of Intensive Care Medicine, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
Marek CzosnykaClinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Peter SmielewskiClinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-5096-3938
Nino StocchettiDepartment of Pathophysiology and Transplants, University of Milan, and Neuroscience Intensive Care Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Ari ErcoleDivision of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-8350-8093
David W NelsonDepartment of Physiology and Pharmacology, Section of Perioperative Medicine and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
CENTER-TBI High Resolution ICU Sub-Study Participants and Investigators
University of Cambridge · GBKarolinska Institutet · SEKU Leuven · BEInnsbruck Medical University · ATKTH Royal Institute of Technology · SEUniversity of Milan · ITWarsaw University of Technology · PL

Funding

CIHR
6 · The paper itself

Abstract

Magnitude of intracranial pressure (ICP) elevations and their duration have been associated with worse outcomes in patients with traumatic brain injuries (TBI), however published thresholds for injury vary and uncertainty about these levels has received relatively little attention. In this study, we have analyzed high-resolution ICP monitoring data in 227 adult patients in the CENTER-TBI dataset. Our aim was to identify thresholds of ICP intensity and duration associated with worse outcome, and to evaluate the uncertainty in any such thresholds. We present ICP intensity and duration plots to visualize the relationship between ICP events and outcome. We also introduced a novel bootstrap technique to evaluate uncertainty of the equipoise line. We found that an intensity threshold of 18 ± 4 mmHg (2 standard deviations) was associated with worse outcomes in this cohort. In contrast, the uncertainty in what duration is associated with harm was larger, and safe durations were found to be population dependent. The pressure and time dose (PTD) was also calculated as area under the curve above thresholds of ICP. A relationship between PTD and mortality could be established, as well as for unfavourable outcome. This relationship remained valid for mortality but not unfavourable outcome after adjusting for IMPACT core variables and maximum therapy intensity level. Importantly, during periods of impaired autoregulation (defined as pressure reactivity index (PRx)>0.3) ICP events were associated with worse outcomes for nearly all durations and ICP levels in this cohort and there was a stronger relationship between outcome and PTD. Whilst caution should be exercised in ascribing causation in observational analyses, these results suggest intracranial hypertension is poorly tolerated in the presence of impaired autoregulation. ICP level guidelines may need to be revised in the future taking into account cerebrovascular autoregulation status considered jointly with ICP levels.

Indexed as

Monitoring, PhysiologicAdultBlood PressureBrain Injuries, TraumaticCerebrovascular CirculationFemaleHemorrhageHumansIntensive Care UnitsIntracranial HypertensionIntracranial PressureMiddle AgedMotor Activity

Identifiers

PMID33315872
PMCPMC7735618
OpenAlexW3110916323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.